CHUR Of Besançon
- Address
- 3 Boulevard Alexander Fleming, Cs 81816
Sponsor Overview
Specializations
Hepatocellular carcinoma
CHUR Of Besançon is involved in clinical research for patients with locally advanced, metastatic, or unresectable hepatocellular carcinoma, with attention to disease control in advanced liver cancer.
- Hepatocellular carcinoma
- Unresectable liver cancer
- Advanced solid tumours
The sponsor’s research activity is centered on a single active trial in this indication, reflecting a focused clinical interest in challenging hepatic malignancies.
Immunotherapy and immune-based cancer treatment
The clinical programme includes investigation of immune checkpoint inhibition alongside a cancer vaccine strategy, with interest in treatment approaches that engage CD4-Th1 immune responses in hepatocellular carcinoma.
- Immune checkpoint therapy
- Cancer vaccine
- CD4-Th1 immune activation
This area of research links immuno-oncology with liver cancer management in patients not eligible for surgical resection.
Anti-angiogenic therapy
Research activity also involves treatment strategies incorporating bevacizumab, with emphasis on tumour-associated angiogenesis in advanced liver cancer.
- Bevacizumab
- Angiogenesis inhibition
- Tumour vascular targeting
The sponsor’s interest in this domain is tied to combined approaches for patients with difficult-to-treat hepatocellular carcinoma.
Clinical oncology and treatment response assessment
The trial landscape includes evaluation of objective response in advanced cancer care, with focus on measurable tumour outcomes in unresectable hepatocellular carcinoma.
- Objective response rate
- Tumour response assessment
- Advanced oncology care
Activity is concentrated in a French hospital setting with collaboration across multiple research sites supporting oncology-focused clinical investigation.
Sponsored Trials
Data & Insights
This sponsor works with 3 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 14 sites across their trial portfolio.
Therapeutic Focus
- 1.Digestive System Diseases1 trial280 other sponsors
Partnered Research Centres
14 centres- Address
- 3 Boulevard Alexandre Fleming, 25000 Besançon
- Address
- 1 Rue Professeur Marion, 21000 Dijon
- Address
- 80 Avenue Augustin Fliche, 34295 Montpellier
- Address
- 2 Rue De La Miletrie, 86000 Poitiers
- Address
- 28 Rue Laennec, 69008 Lyon
- Address
- Boulevard De La Chantourne, Cs 10217, La Tronche, 38043 La Tronche
Want to get in touch with this sponsor?
Send a question and we'll pass it on to CHUR Of Besançon.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.